ENTITY
3SBio Inc

3SBio Inc (1530 HK)

151
Analysis
Health CareChina
3SBio, Inc. is a biotechnology company located in China. The Company focuses on mammalian cell-based biopharmaceuticals in the biotechnology industry. 3SBio also develops, manufactures and markets biopharmaceutical products globally.
more
30 Jan 2019 10:22

Shanghai Henlius (复宏汉霖) IPO: Not an Impressive Biosimilar Portfolio

Shanghai Henlius, a subsidiary of Fosun Pharma, is seeking to list in Hong Kong. In this insight, we will discuss the following topics: The...

Logo
1.3k Views
Share
bullishCRRC Corp Ltd H
28 Jan 2019 15:45

HK Connect Discovery Weekly: CRRC, Car Inc/UCar (2019-01-25)

In our Discover HK Connect series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed by...

Logo
600 Views
Share
09 Jan 2019 09:55

HK Connect Discovery Weekly: CR Beer, Great Wall Motors, and Kingsoft (2019-01-07)

In our Discover HK Connect series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed by...

Logo
784 Views
Share
02 Jan 2019 15:09

Discover HK Connect: Mainlanders Were Buying Pharma and Property Managers in December

In our Discover HK Connect series, we aim to help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed by...

Logo
756 Views
Share
bullishTingyi Holding
10 Dec 2018 09:10

Discover HK Connect: Mainlanders Are Buying Shandong Gold, Tingyi, YiChang HEC (2018-12-10)

In our Discover HK Connect series, we will help our investors understand the flow of southbound trades via the Hong Kong Connect, as analyzed by...

Logo
433 Views
Share
x